论文部分内容阅读
目的探讨临床药师参与代谢综合征患者血脂异常的规范化治疗和药学监护的意义。方法临床药师参与血脂异常的代谢综合征患者的规范化调脂治疗过程,并对患者实施药学监护、健康教育和用药教育等。结果临床药师干预后患者的血脂水平、膳食结构、治疗依从性等均较干预前有明显改善;血脂异常的代谢综合征患者的治疗过程经临床药师干预后,未发生严重药物不良事件。结论临床药师参与代谢综合征患者的调脂治疗并通过药学监护和患者教育,可及时发现和解决患者治疗过程中的潜在问题,有助于提高患者的治疗效果,避免严重药物不良反应的发生。
Objective To investigate the clinical pharmacists involved in metabolic syndrome patients with dyslipidemia standardization and the significance of pharmacy care. Methods Clinical pharmacists participated in the standardization of lipid-lowering treatment for patients with metabolic syndrome with dyslipidemia, and implemented pharmacy care, health education and medication education for patients. Results After the intervention of clinical pharmacists, the blood lipid level, dietary structure and treatment compliance of patients were significantly improved compared with that before intervention. The treatment course of dyslipidemia patients with metabolic syndrome did not occur serious adverse drug events after intervention by clinical pharmacists. Conclusion Clinical pharmacists are involved in the lipid-lowering treatment of patients with metabolic syndrome. Through pharmacological monitoring and patient education, clinical pharmacists can find and solve potential problems in the course of treatment and help to improve the therapeutic effect of patients and avoid serious adverse drug reactions.